National Biologics Facility

Our Publications

Peer-reviewed research and innovation supported by the National Biologics Facility.

Publication Archive

2024 14
Amino acid degradation pathway inhibitory by-products trigger apoptosis in CHO cells
Pyroptotic cell corpses are crowned with F-actin-rich filopodia that engage CLEC9A signaling in incoming dendritic cells
mRNArchitect: Optimized design of mRNA sequences
Isolation and Characterization of Antibodies Against Vascular Cell Adhesion Molecule-1 Reveals Putative Role for Ig-like Domains 2 and 3 in Cell-to-Cell Interaction
Rational Design of Advanced Gene Delivery Carriers: Macrophage Phenotype Matters
Targeted mRNA delivery with bispecific antibodies that tether LNPs to cell-surface markers
A scalable, spin-free approach to generate enhanced induced pluripotent stem cell-derived natural killer cells for cancer immunotherapy
Limited potential of sheep as a large animal to model transfusion-related acute lung injury mediated by antibodies against human neutrophil antigen 3a
The immune checkpoint TIGIT is upregulated on T cells during bacterial infection and is a potential target for immunotherapy
Liver and pancreatic-targeted interleukin-22 as a therapeutic for metabolic dysfunction-associated steatohepatitis
EGFR Targeting of Liposomal Doxorubicin Improves Recognition and Suppression of Non-Small Cell Lung Cancer
Harnessing metabolic plasticity in CHO cells for enhanced perfusion cultivation
Targeted delivery of polo-like kinase 1 siRNA nanoparticles using an EGFR-PEG bispecific antibody inhibits proliferation of high-risk neuroblastoma
Messenger RNA-encoded antibody approach for targeting extracellular and intracellular tau

No publications found

Try a different search term

NBF is proudly supported by

NCRIS Therapeutic Innovation Australia The University of Queensland